Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCAA Supplementation in HCC
NCT03908255Phase 2Withdrawn
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- Jun 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Branchamin in hepatocellular carcinoma (HCC), sponsored by Louisiana State University Health Sciences Center. Planned start Jun 2021; status: withdrawn.
02
Drugs
Branchamin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03908255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03908255.